SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-035852
Filing Date
2018-06-26
Accepted
2018-06-26 16:54:42
Documents
1
Period of Report
2018-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv497342_form4.html 4  
1 FORM 4 tv497342_form4.xml 4 8944
  Complete submission text file 0001144204-18-035852.txt   11462
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 110287
Business Address
Chiesi Giacomo (Reporting) CIK: 0001744492 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 18919805

Mailing Address P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 110287
Business Address P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 110287 919-998-3300
Chiesi Ventures, Inc. (Reporting) CIK: 0001744577 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 18919803

Mailing Address P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 110287
Business Address P.O. BOX 110287 RESEARCH TRIANGLE PARK NC 110287 919-998-3300
Chiesi Ventures, LP (Reporting) CIK: 0001744641 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 18919804